Dominant negative allele (N47D) in a compound heterozygote for a variant of 6-pyruvoyltetrahydropterin synthase deficiency causing transient hyperphenylalaninemia. 1999

T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
Division of Clinical Chemistry and Biochemistry, University Children's Hospital, Zurich, Switzerland.

Mutations in the 6-pyruvoyltetrahydropterin synthase (PTPS) gene result in persistent hyperphenylalaninemia and severe catecholamine and serotonin deficiencies. We investigated at the DNA level a family with a PTPS-deficient child presenting with an unusual form of transient hyperphenylalaninemia. The patient exhibited compound heterozygosity for the PTPS-mutant alleles N47D and D116G. Transfection studies with single PTPS alleles in COS-1 cells showed that the N47D allele was inactive, while D116G had around 66% of the wild-type activity. Upon co-transfection of two PTPS alleles into COS-1 cells, the N47D allele had a dominant negative effect on both the wild-type PTPS and the D116G mutant with relative reduction to about 20% of control values. Whereas the mother and the father had reduced enzyme activity in red blood cells (34.7% and 51.7%, respectively) and skin fibroblasts (2.8% and 15.4%, respectively), the clinically normal patient had in these cells activities at the detection limits, although PTPS-cross-reactive material was present in the fibroblasts. The specifically low PTPS activity in the mother's cells corroborated the evidence of a dominant negative effect of the maternal N47D allele on wild-type PTPS.

UI MeSH Term Description Entries
D008297 Male Males
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females
D005799 Genes, Dominant Genes that influence the PHENOTYPE both in the homozygous and the heterozygous state. Conditions, Dominant Genetic,Dominant Genetic Conditions,Genetic Conditions, Dominant,Condition, Dominant Genetic,Dominant Gene,Dominant Genes,Dominant Genetic Condition,Gene, Dominant,Genetic Condition, Dominant
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections

Related Publications

T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
December 1998, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology,
T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
June 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
December 1995, The Journal of biological chemistry,
T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
December 1999, Clinical chemistry,
T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
November 1994, Genomics,
T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
June 2003, The Journal of clinical endocrinology and metabolism,
T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
July 2005, Annals of neurology,
T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
July 2019, Pediatric neurology,
T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
May 2014, Acta crystallographica. Section D, Biological crystallography,
T Scherer-Oppliger, and A Matasovic, and S Laufs, and H L Levy, and E J Quackenbush, and N Blau, and B Thöny
May 1991, Neurology,
Copied contents to your clipboard!